| Literature DB >> 32954902 |
Edward S Bliss1, Rachel Hx Wong2,3, Peter Rc Howe2,3,4, Dean E Mills1.
Abstract
Derangements in cerebrovascular structure and function can impair cognitive performance throughout ageing and in cardiometabolic disease states, thus increasing dementia risk. Modifiable lifestyle factors that cause a decline in cardiometabolic health, such as physical inactivity, exacerbate these changes beyond those that are associated with normal ageing. The purpose of this review was to examine cerebrovascular, cognitive and neuroanatomical adaptations to ageing and the potential benefits of exercise training on these outcomes in adults 50 years or older. We systematically searched for cross-sectional or intervention studies that included exercise (aerobic, resistance or multimodal) and its effect on cerebrovascular function, cognition and neuroanatomical adaptations in this age demographic. The included studies were tabulated and described narratively. Aerobic exercise training was the predominant focus of the studies identified; there were limited studies exploring the effects of resistance exercise training and multimodal training on cerebrovascular function and cognition. Collectively, the evidence indicated that exercise can improve cerebrovascular function, cognition and neuroplasticity through areas of the brain associated with executive function and memory in adults 50 years or older, irrespective of their health status. However, more research is required to ascertain the mechanisms of action.Entities:
Keywords: Dementia; ageing; cerebrovascular function; cognition; exercise training
Mesh:
Year: 2020 PMID: 32954902 PMCID: PMC7907999 DOI: 10.1177/0271678X20957807
Source DB: PubMed Journal: J Cereb Blood Flow Metab ISSN: 0271-678X Impact factor: 6.200
Figure 1.Ageing is associated with hormonal imbalances and increased low-grade systemic inflammation. It is also associated with the increased production of reactive oxygen species (ROS), which may be due to diminished nuclear regulation factor 2 and superoxide dismutase expression and increased expression of nicotinamide adenine dinucleotide phosphate oxidase complexes, resulting in increased mitochondrial superoxide production.[120] Uncoupled endothelial nitric oxide (NO) synthase (eNOS) increases superoxide production by catalysing nicotinamide adenine dinucleotide phosphate, instead of synthesising NO. Increased arginase activity reduces l-arginine supply, thus promoting the uncoupling of eNOS.[69,70] This may also be associated with diminished tetrahydrobiopterin availability and increased asymmetrical dimethylarginine concentrations, which subsequently acts as a competitive inhibitor of eNOS, thus reducing NO biosynthesis.[71] These promote and lead to endothelial dysfunction, which subsequently manifests as local ischemia and micro-haemorrhages in the microvasculature, leading to reductions in capillary density and BBB function (i.e. reduced cerebrovascular function).[121,122] It may also be a result of increased conduit artery stiffness, which then diffuses to the cerebral circulation and increases pulsatility of the cerebral microvasculature, reducing CBF and promoting ischaemic-induced leukoaraiosis.[123] Nevertheless, increased inflammation and oxidative stress, hypoperfusion and decreased BBB integrity are potentiated by these events.[3,121,124–128] This subsequently promotes increased microglial activity, amyloid-β production and decreased amyloid-β clearance, which may act as a trigger for enhanced S100B and glial fibrillary acidic protein secretion to form astrocytes, thus promoting the inflammatory cycle and the continued accumulation of neurotoxic products.[3,121,124–128] Further, the increase in amyloid-β accumulation in the brain can further compromise cerebrovascular function that manifests into neurodegeneration and further structural and functional changes within the brain.[129]
Summary of the cognitive domain changes throughout the lifespan.
| References | Cognitive domain | Stable, increases or decreases |
|---|---|---|
| Harada et al.,[ | Processing speed | Decreases (from third decade of life) |
| Harada et al.,[ | Attention | Decreases (later life) |
| Harada et al.,[ | Memory | Decreases (episodic – throughout life; semantic – later
life) |
| Harada et al.,[ | Language
| Increases |
| Harada et al.,[ | Visuospatial ability | Stable |
| Harada et al.,[ | Executive function | Decreases (throughout life, rapid from seventh decade of
life) |
Figure 2.A summary of the potential mechanisms that may be elicited by exercise in improving cerebrovascular function and cognition. CBF: cerebral blood flow; eNOS: endothelial nitric oxide synthase, NO: nitric oxide; BHB: beta-hydroxybutyrate; GH: growth hormone; VEGF: vascular endothelial growth factor; BDNF: brain-derived neurotrophic factor; IGF1: insulin-like growth factor-1; PGC-1a: peroxisome proliferator-activated receptor gamma coactivator 1-alpha.
Summary of research that has examined the effects of aerobic exercise training on cerebrovascular function, cognition and neural structural adaptations.
| References | Study design | Participant description | Group allocation | Primary method used to evaluate CBF/cognition | Effect of exercise on primary outcome | Effect of exercise on other outcomes |
|---|---|---|---|---|---|---|
| Cerebrovascular function | ||||||
|
| ||||||
| Ainslie et al.19 | Cross-sectional | Healthy males (17–79 years old)
| Trained ( | TCD | ↑ MCA CBFV (9.1 cm·s−1·year−1 of life) | ↑ |
| Akazawa et al.20 | Non-randomised control trial | Healthy adults (52–66 years old) | Exercise ( | TCD | ↓ cerebral pulsatility index | ↓ arterial stiffness |
| Brown et al.26 | Cross-sectional | Females (50–90 years old) | Trained ( | TCD | ↑ cerebrovascular conductance | ↓ resting mean arterial pressure |
| Chapman et al.28 | Randomised control trial | Healthy adults (57–75 years old) | Exercise ( | MRI | ↑ ACC blood flow | ↑ memory performance |
| Maass et al.37 | Randomised control trial | Healthy adults (60–77 years old) | Exercise ( | MRI | ↑ | ↑ hippocampal perfusion in younger participants |
| Vicente-Campos et al.46 | Randomised control trial | Health adults (60–75 years old) | Exercise ( | TCD | ↑ vasomotor reactivity | ↑ waking velocity & cardiorespiratory capacity |
|
| ||||||
| Anazodo et al.21 | Non-randomised control trial | Adults | Exercise ( | ASL | ↑ ACC blood flow | ↓ resting CBF and CVR to |
| Ivey et al.33 | Randomised control trial | Adults (>60 years old) | Exercise ( | TCD | ↑ bilateral cerebrovascular vasomotor reactivity | ↑ |
| Cognition | ||||||
|
| ||||||
| Anderson-Hanley et al.22 | Randomised control trial | Adults (≥55 years old) | Cycle | Cognitive battery | ↑ score on cognitive battery | ↑ BDNF |
|
| ||||||
| Baker et al.23 | Randomised control trial | Adults (55–85 years old) | Exercise ( | Cognitive battery | ↑ cognitive scores in multiple tests (female) | ↓ CHO & LDL |
|
| ||||||
| Hoffmann et al.32 | Randomised control trial | Adults (50–90 years old) | Exercise ( | SDMT (cognitive testing) | No change between the two arms of the study | ↑ Neuropsychiatric inventory from baseline (experimental arm only) |
| Sobol et al.43 | Cross-sectional | Adults (50–90 years old) | Undefined ( | Cognitive battery | ↑ cognition correlated with ↑ 30 s chair sit-to-stand performance | ↑ dual-task performance correlated with ↑ performance in the cognitive battery |
|
| ||||||
|
| ||||||
| Erickson et al.30 | Randomised control trial | Healthy adults (55–80 years old) | Exercise ( | MRI | ↑ hippocampal volume | ↑ spatial memory |
|
| ||||||
| Chirles et al.29 | Non-randomised control trial | Adults (60–88 years old) | MCI (exercise; | MRI | ↑ right parietal lobe connectivity (MCI group) | ↑ neural connectivity from baseline (MCI group) |
| Smith et al.42 | Non-randomised control trial | Adults (60–88 years old) | MCI (exercise; | MRI | ↑ semantic memory | ↑ |
TCD: transcranial Doppler ultrasound; ASL: arterial spin labelling; MRI: magnetic resonance imaging; CBF: cerebral blood flow; CBFV: cerebral blood flow velocity; MCA: middle cerebral artery; ACC: anterior cingulate cortex; CVR: cerebrovascular responsiveness. SDMT: symbol digit modalities test; CHO: total cholesterol; LDL: low-density lipoprotein; TG: triglycerides; BMI: body mass index; IGF1: insulin-like growth factor-1; HOMA-IR: homeostatic model assessment of insulin resistance; BDNF: brain-derived neurotrophic factor; MCI: mild cognitive impairment.
Summary of research that has examined the effects of resistance exercise training on cerebrovascular function, cognition and neural structural adaptations.
| References | Study design | Participant description | Group allocation | Primary method used to evaluate CBF/cognition | Effect of exercise on primary outcome | Effect of exercise on other outcomes |
|---|---|---|---|---|---|---|
| Cerebrovascular function | ||||||
|
| ||||||
| Xu et al.89 | Cross-sectional | Adults (57–76 years
old) | Total participants ( | MRI | ↑ cerebrovascular perfusion (strength-trained females) | No association between ↑ cerebral perfusion with either aerobic or flexibility training |
| Cognition | ||||||
|
| ||||||
| Busse et al.93 | Randomised control trial | Adults (62–86 years old) | Exercise ( | Cognitive battery | ↑ memory performance | ↑ muscle strength |
| Cassilhas et al.27 | Randomised control trial | Healthy males (65–75 years old) | Moderate intensity | Cognitive battery | ↑ cognition, memory and executive function | ↓ POMS score (↑ performance) |
|
| ||||||
| Fiatarone Singh et al.31 | Randomised control trial | Adults (>55 years old) | Exercise + sham cognitive training ( | ADAS-cog | ↑ ADAS-cog performance post intervention | ↑ executive function |
| Neural structural adaptations | ||||||
|
| ||||||
| Bolandzadeh et al.24, | Randomised control trial | Females (65–75 years old) | 1 × 60 min/week | MRI | ↑ Stroop performance (↑10.9-12.6%) | ↓ white matter lesions (2 sessions/week) |
| Nagamatsu et al.39 | Randomised control trial | Females (70–80 years old) | Aerobic exercise ( | MRI | ↑ Stroop test performance | ↑ cardiovascular capacity |
MRI: magnetic resonance imaging; ADAS-Cog: Alzheimer disease assessment scale–cognitive subscale; POMS: profile of mood states; RAVLT: Rey’s auditory verbal learning test; IGF1: insulin-like growth factor-1; MCI: mild cognitive impairment.
Summary of research that has examined the effects of multimodal exercise training on cognition and neural structural adaptations.
| References | Study design | Participant description | Group allocation | Primary method used to evaluate CBF/cognition | Effect of exercise on primary outcome | Effect of exercise on other outcomes |
|---|---|---|---|---|---|---|
| Cerebrovascular function | ||||||
|
| ||||||
| Moore et al.38 | Randomised control trial | Adults (>50 years old) | Exercise ( | MRI | ↑ middle temporal lobe tissue CBF | No change in HOMA-IR |
| Cognition | ||||||
|
| ||||||
| Bossers et al. 25 | Randomised control trial | Adults (80–90 years old) | Multimodal exercise ( | Cognitive battery | ↑ global cognition, visual & verbal memories, executive
function (multimodal exercise) | ↑ walking endurance, muscle strength & balance
(multimodal exercise) |
| Vreugdenhil et al.47 | Randomised control trial | Adults (mean 77 years old) | Exercise ( | MMSE | ↑ MMSE scores (2.6 points) | ↑ lower body strength |
|
| ||||||
| Lautenschlager et al.34 | Randomised control trial | Healthy adults (>50 years old) | Exercise ( | ADAS-Cog | ↑ 0.26 points post-intervention | ↑ physical activity 18 months post intervention |
| Neural structural adaptations | ||||||
|
| ||||||
| Nishiguchi et al.40 | Randomised control trial | Healthy adults (>60 years old) | Exercise ( | MRI | ↑ memory and executive function | ↑ average daily steps (54%) |
|
| ||||||
| Suzuki et al.44 | Randomised control trial | Adults (55–95 years old) | Exercise ( | MRI | ↓ whole brain cortical atrophy | ↓ baseline CHO and ↑ BDNF associated with improvements in cognitive function pre-exercise |
ADAS-Cog: Alzheimer disease assessment scale–cognitive subscale; MMSE: mini-mental state examination; MRI: magnetic resonance imaging; ACE: Addenbrooke’s cognitive examination; CHO: total cholesterol; BDNF: brain-derived neurotrophic factor; MCI: mild cognitive impairment.